Cargando…

The Role of Hypoxia in Glioblastoma Radiotherapy Resistance

SIMPLE SUMMARY: Glioblastoma (GB) is the deadliest type of primary brain tumor. Following diagnosis the patient´s median survival is only 16 months. There are currently around 450 clinical trials focused on the development of more effective therapies for GB. Nevertheless, radiotherapy remains the mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chédeville, Agathe L., Madureira, Patricia A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867045/ https://www.ncbi.nlm.nih.gov/pubmed/33535436 http://dx.doi.org/10.3390/cancers13030542

Ejemplares similares

Investigating Glioblastoma Response to Hypoxia
por: Chédeville, Agathe L., et al.
Publicado: (2020)

The Role of Hypoxia in Glioblastoma Invasion
por: Monteiro, Ana Rita, et al.
Publicado: (2017)

Hypoxia: The Cornerstone of Glioblastoma
por: Domènech, Marta, et al.
Publicado: (2021)

The Role of Hypoxia and Cancer Stem Cells in Development of Glioblastoma
por: Shi, Tingyu, et al.
Publicado: (2023)

The evolving roles and controversies of radiotherapy in the treatment of glioblastoma
por: Hau, Eric, et al.
Publicado: (2016)

The Role of Hypoxia and SRC Tyrosine Kinase in Glioblastoma Invasiveness and Radioresistance
por: Torrisi, Filippo, et al.
Publicado: (2020)

Biomimetic hypoxia-triggered RNAi nanomedicine for synergistically mediating chemo/radiotherapy of glioblastoma
por: Wang, Zhen, et al.
Publicado: (2023)

The critical role of ERK in death resistance and invasiveness of hypoxia-selected glioblastoma cells
por: Kim, Jee-Youn, et al.
Publicado: (2009)

Radiotherapy resistance acquisition in Glioblastoma. Role of SOCS1 and SOCS3
por: Ventero, Maria Paz, et al.
Publicado: (2019)

Therapy Resistance of Glioblastoma in Relation to the Subventricular Zone: What Is the Role of Radiotherapy?
por: Ermiş, Ekin, et al.
Publicado: (2023)

Glioblastoma multiforme: Effect of hypoxia and hypoxia inducible factors on therapeutic approaches
por: Huang, Wen-Juan, et al.
Publicado: (2016)

Overcoming the Impact of Hypoxia in Driving Radiotherapy Resistance in Head and Neck Squamous Cell Carcinoma
por: Hill, Rhianna M., et al.
Publicado: (2022)

Interfering with Tumor Hypoxia for Radiotherapy Optimization
por: Telarovic, Irma, et al.
Publicado: (2021)

Correction: Radiotherapy resistance acquisition in Glioblastoma. Role of SOCS1 and SOCS3
por: Ventero, Maria Paz, et al.
Publicado: (2019)

Hypoxia and glioblastoma therapy
por: Yang, Chunzhang, et al.
Publicado: (2015)

The potential of advanced MR techniques for precision radiotherapy of glioblastoma
por: Tang, Patrick L. Y., et al.
Publicado: (2022)

The role of ion channels in the hypoxia-induced aggressiveness of glioblastoma
por: Sforna, Luigi, et al.
Publicado: (2015)

Stress Response Leading to Resistance in Glioblastoma—The Need for Innovative Radiotherapy (iRT) Concepts
por: Combs, Stephanie E., et al.
Publicado: (2016)

Advanced nanomaterials targeting hypoxia to enhance radiotherapy
por: Li, Jia, et al.
Publicado: (2018)

Advances in Radiotherapy for Glioblastoma
por: Mann, Justin, et al.
Publicado: (2018)

The Role of microRNAs in Multidrug Resistance of Glioblastoma
por: Mahinfar, Parvaneh, et al.
Publicado: (2022)

The role of extracellular vesicles in acquisition of resistance to therapy in glioblastomas
por: Yekula, Anudeep, et al.
Publicado: (2021)

Current Understanding of Hypoxia in Glioblastoma Multiforme and Its Response to Immunotherapy
por: Park, Jang Hyun, et al.
Publicado: (2022)

Combination of palbociclib and radiotherapy for glioblastoma
por: Whittaker, Shane, et al.
Publicado: (2017)

Tumor hypoxia and reoxygenation: the yin and yang for radiotherapy
por: Hong, Beom-Ju, et al.
Publicado: (2016)

Hypoxia imaging and radiotherapy: bridging the resolution gap
por: Grimes, David Robert, et al.
Publicado: (2017)

Small Molecules and Immunotherapy Agents for Enhancing Radiotherapy in Glioblastoma
por: Matsui, Jennifer K., et al.
Publicado: (2022)

Hypoxia upregulates HIG2 expression and contributes to bevacizumab resistance in glioblastoma
por: Mao, Xing-gang, et al.
Publicado: (2016)

Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors
por: Méndez-Blanco, Carolina, et al.
Publicado: (2018)

Deciphering the Role of Autophagy in Treatment of Resistance Mechanisms in Glioblastoma
por: Khan, Imran, et al.
Publicado: (2021)

Glioblastoma, hypoxia and autophagy: a survival-prone ‘ménage-à-trois'
por: Jawhari, Soha, et al.
Publicado: (2016)

Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma—A Critical Review
por: Komotar, Ricardo J., et al.
Publicado: (2008)

The impact of hypoxia and its modification of the outcome of radiotherapy
por: Horsman, Michael R., et al.
Publicado: (2016)

Bevacizumab and radiotherapy for the treatment of glioblastoma: brothers in arms or unholy alliance?
por: Niyazi, Maximilian, et al.
Publicado: (2015)

Radiotherapy-drug combinations in the treatment of glioblastoma: a brief review
por: McAleavey, Patrick G, et al.
Publicado: (2022)

Radiotherapy for Newly Diagnosed Glioblastoma in the Elderly: What Is the Standard?
por: Wee, Chan Woo
Publicado: (2022)

The need of radiotherapy optimization for glioblastomas considering immune responses
por: Nishioka, Kentaro, et al.
Publicado: (2023)

The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy
por: Muz, Barbara, et al.
Publicado: (2015)

Roles of Chromatin Remodelling and Molecular Heterogeneity in Therapy Resistance in Glioblastoma
por: Chen, Huey-Miin, et al.
Publicado: (2022)

Radiosensitizing high-Z metal nanoparticles for enhanced radiotherapy of glioblastoma multiforme
por: Choi, Jinyeong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_69ogjvkip6ddbhvi9aq513c8ub